tiprankstipranks
Sigyn Therapeutics (SIGY)
OTHER OTC:SIGY
US Market
Want to see SIGY full AI Analyst Report?

Sigyn Therapeutics (SIGY) Financial Statements

14 Followers

Sigyn Therapeutics Financial Overview

Sigyn Therapeutics's market cap is currently $46.56K. The company's EPS TTM is $-2.09; its P/E ratio is -0.01; Sigyn Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -1.36K$ -5.61K$ -8.86K$ -10.45K-
Operating Income$ -1.79M$ -2.52M$ -2.46M$ -2.15M$ -2.01M
EBITDA$ -1.78M$ -2.52M$ -2.45M$ -2.14M$ -2.53M
Net Income$ -3.36M$ -3.34M$ -4.15M$ -3.71M$ -3.40M
Balance Sheet
Cash & Short-Term Investments$ 20.33K$ 12.14K$ 11.69K$ 8.36K$ 340.96K
Total Assets$ 107.52K$ 213.72K$ 321.81K$ 332.88K$ 710.26K
Total Debt$ 3.06M$ 2.19M$ 2.40M$ 1.88M$ 980.01K
Net Debt$ 3.04M$ 2.18M$ 2.39M$ 1.87M$ 639.05K
Total Liabilities$ 6.55M$ 4.67M$ 3.73M$ 2.24M$ 974.84K
Stockholders' Equity$ -6.44M$ -4.46M$ -3.41M$ -1.90M$ -264.58K
Cash Flow
Free Cash Flow$ -852.28K$ -872.44K$ -1.38M$ -1.83M$ -1.80M
Operating Cash Flow$ -852.27K$ -872.44K$ -1.38M$ -1.83M$ -1.77M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ -860.00$ -29.26K
Financing Cash Flow$ 860.46K$ 872.89K$ 1.39M$ 1.50M$ 2.06M
Currency in USD

Sigyn Therapeutics Earnings and Revenue History

Sigyn Therapeutics Debt to Assets

Sigyn Therapeutics Cash Flow

Sigyn Therapeutics Forecast EPS vs Actual EPS